Table 2 Types of insulin therapy according to geographic region
| Â | Insulin Monotherapy * | Â | Â | |
|---|---|---|---|---|
Type of insulin monotherapy | Southeast | South | Northeast/North | Mid-west |
NPH | 152 (96.8) | 41 (83.7) | 275 (94.5) | 54 (87.1) |
Glargine or Detemir | 5 (3.2) | 8 (16.3) | 16 (5.5) | 8 (12.9) |
| Â | Combined Insulin Therapy** | Â | Â | |
Type of combination of insulin therapy | Southeast | South | Northeast/North | Mid-west |
NPH plus Regular | 573 (46.2) | 357 (46.9) | 677 (82.7) | 79 (47.0) |
NPH plus Lispro | 271 (21.8) | 194 (25.5) | 12 (1.5) | 11 (6.5) |
NPH plus Aspart | 91 (7.3) | 38 (5.0) | 13 (1.6) | 4 (2.4) |
NPH plus Glulisine | 6 (0.5) | 4 (0.5) | 7 (0.9) | 5 (3) |
Glargine plus regular | 16 (1.3) | 12 (1.6) | 10 (1.2) | 1 (0.6) |
Glargine plus Lispro | 158 (12.7) | 71 (9.3) | 25 (3.1) | 48 (28.6) |
Glargine plus Aspart | 57 (4.6) | 67 (8.8) | 32 (3.9) | 6 (3.6) |
Glargine plus Glulisine | 2 (0.2) | 3 (0.4) | 3 (0.4) | 13 (7.7) |
Detemir plus regular | 4 (0.3) | - | 5 (0.6) | - |
Detemir plus Lispro | 25 (2) | 3 (0.4) | 9 (1.1) | 1 (0.6) |
Detemir plus Aspart | 37 (3) | 12 (1.6) | 24 (2.9) | - |
Detemir plus Glulisine | 1 (0.1) | - | 2 (0.2) | - |